Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
32.45
+0.16 (0.50%)
At close: Apr 15, 2025, 4:00 PM
32.50
+0.05 (0.15%)
After-hours: Apr 15, 2025, 5:00 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $18.71 billion as of April 15, 2025. Its market cap has increased by 37.89% in one year.
Market Cap
18.71B
Enterprise Value
25.27B
1-Year Change
37.89%
Ranking
Category
Stock Price
$32.45
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $18.71B, an increase of 18.69%. That is a compound annual growth rate of 3.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2025 | 13.99B | 23.45% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.70B |
| UnitedHealth Group | 548.34B |
| Johnson & Johnson | 365.65B |
| AbbVie | 309.66B |
| Novo Nordisk | 283.15B |
| Abbott Laboratories | 220.05B |
| AstraZeneca | 202.51B |
| Novartis AG | 200.23B |